Abstract:Aims The mutation of BRCA1 is reported to be linked to the onset of triple negative breast cancer (TNBC). However, the incidence of mutation of BRCA1 in Chinese woman is very low. Recent studies have identified genes that encode proteins that interact with BRCA1 as modifiers of BRCA1-associated breast cancer. We evaluated a comprehensive set of genes that encode most known BRCA1 interactors to evaluate the role of these genes as modifiers of TNBC risk in Chinese Han woman. Methods After a proven by IRB, totally 414 patients with TNBC treated in Fudan University Shanghai Cancer Center and 354 healthy women were recruited in this study. Written informed consents were obtained before their recruitment. The DNA from their peripheral blood were obtained. The single nucleotide polymorphisms (SNPs) investigated in this study were consisted of SNPs reported in literatures, SNPs in function region (exons, intron-exon binding regions, promoters and 5’UTR) with MAF larger than 0.05 and tag SNPs in intron. In addition, SNPs that showed significant deviations ( Results An association was observed between TNBC risk and rs7250266 at BABAM1. The allelic frequency for the G-allele of rs7250266 was 0.19 in controls compared with 0.14 in patients, with significant difference. A comparison of genotyping frequency between cases and controls indicated that GC genotype of rs7250266 were associated with significantly decreased TNBC risk (OR of GC genotype 0.70, 95% CI 0.51-0.97, OR of GG genotype 0.48, 95% CI 0.21-1.07, P = 0.03). Under a dominant model, it9s shown that women with genotypes GC/GG of re7250266 conferred approximately 33% decreased risk to the development of breast cancer (OR 0.67, 95% CI 0.49-0.92, P = 0.01). Another SNP at BABAM1, rs2278256 showed a borderline association with the risk of TNBC. It is also in one linkage disequilibrium (LD) block with rs7250266. Two haplotypes at BABAM1 were demonstrated to be associated with a decrease risk of TNBC. Conclusions We investigated 37 SNPs in 5 BRCA1-associated genes and demonstrated the mutation of rs7250266 was associated with a decrease risk of developing TNBC in Chinese women. It9s the first time this SNP was reported to be associated with breast cancer. Further analysis confirmed haplotypes with mutation of rs7250266 and rs2278256 had a lower risk of developing TNBC than other haplotypes. Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P3-07-07.

Association between BRCA1 gene tag SNP and sensitivity to anthracycline-based chemotherapy among Chinese Northwestern Han population

Association of Base Excision Repair Gene Polymorphisms with the Response to Chemotherapy in Advanced Non-Small Cell Lung Cancer

Association of single nucleotide polymorphisms and haplotypes in DNA repair gene XRCC1 with susceptibility of breast cancer]

[Association of XPC gene polymorphisms with breast cancer risk].

Correlations of Single Nucleotide Polymorphisms of DNA Repair Gene XRCC1 to Risk of Colorectal Cancer

Breast cancer association studies in a Han Chinese population using 10 European-ancestry-associated breast cancer susceptibility SNPs

ERCC1 rs3212986 A/C polymorphism is not associated with chemotherapy treatment outcomes in gastric cancer patients: evidence from 11 publications in Chinese populations.

Association of BRCA1 K1183R polymorphism with survival in BRCA1/2-negative chinese familial breast cancer.

A Genetic Polymorphism In Pre-Mir-27a Confers Clinical Outcome Of Non-Small Cell Lung Cancer In A Chinese Population

The Association of CASC16 Variants with Breast Cancer Risk in a Northwest Chinese Female Population

&Lt;em>ercc1</em> Rs3212986 A/C Polymorphism is Not Associated with Chemotherapy Treatment Outcomes in Gastric Cancer Patients: Evidence from 11 Publications in Chinese Populations

Abstract P3-07-07: Single nucleotide polymorphisms of BRCA1-interacting genes are associated with triple-negative breast cancer in Chinese Han woman

Association between the CASC16 rs4784227 polymorphism and breast cancer risk and prognosis in a northeast Chinese Han population

Genome-wide association study identifies four SNPs associated with response to platinum-based neoadjuvant chemotherapy for cervical cancer

A Single-Nucleotide Polymorphism of the Beta 2-Adrenergic Receptor Gene Can Predict Pathological Complete Response to Taxane- and Platinum-Based Neoadjuvant Chemotherapy in Breast Cancer.

Evaluating the Association of Eight Polymorphisms with Cancer Susceptibility in a Han Chinese Population

The impact of EGFR gene polymorphisms on the response and toxicity derived from neoadjuvant chemotherapy for breast cancer.

Prevalence of BRCA 1 mutations and responses to neoadjuvant chemotherapy among BRCA 1 carriers and non-carriers with triple-negative breast cancer

Predictive Value of BRCA1/2 Mrna Expression for Response to Neoadjuvant Chemotherapy in BRCA‐negative Breast Cancers

Association of Multiple Genetic Variants with Breast Cancer Susceptibility in the Han Chinese Population

Prognostic and Predictive Markers for Early Stage Triple‐Negative Breast Cancer Treated With Platinum‐Based Neoadjuvant Chemotherapy